Ascendis Pharma A/S - ASND
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | History | No change | 225,155 | 60,053 | 1.31% | 1.31% | 1 | 0 | 0.0% | Q2 2026 | Aug 14, 2026 |
| Neuberger Berman Group LLC | History | No change | 142,705 | 38,062 | 0.03% | 0.03% | 2 | 0 | 0.0% | Q2 2026 | Oct 27, 2026 |
| ODDO BHF ASSET MANAGEMENT SAS | History | No change | 128,657 | 34,315 | 1.59% | 1.59% | 3 | 0 | 0.0% | Q2 2026 | Aug 13, 2026 |
| Quadrature Capital Ltd | History | No change | 40,845 | 10,894 | 0.09% | 0.09% | 4 | 0 | 0.0% | Q2 2026 | Aug 06, 2026 |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | History | No change | 2,600 | 592 | 0.01% | 0.01% | 5 | 0 | 0.0% | Q3 2026 | Oct 05, 2026 |
| DEARBORN PARTNERS LLC | History | No change | 1,300 | 297 | 0.02% | 0.02% | 6 | 0 | 0.0% | Q2 2026 | Aug 13, 2026 |
| E Fund Management (Hong Kong) Co., Ltd. | History | No change | 84 | 22 | 0.01% | 0.01% | 7 | 0 | 0.0% | Q2 2026 | Jul 22, 2026 |
| Ninepoint Partners LP | History | No change | 26 | 6 | 0.0% | 0.0% | 8 | 0 | 0.0% | Q2 2026 | Aug 11, 2026 |
| IFP Advisors, Inc | History | Closed out | 0 | 0 | — | 0.0% | — | -14 | -100.0% | Q3 2026 | Oct 16, 2026 |
| HUNTINGTON NATIONAL BANK | History | No change | 1 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Aug 13, 2026 |